Meihua International Medical Technologies Co Ltd's asset turnover ratio, the ratio that measures the ability of Meihua International Medical Technologies Co Ltd's assets to generate revenue, sequentially decreased to 0.29 in the fourth quarter (Dec 31 2025), which does not come as a surprise, as the Meihua International Medical Technologies Co Ltd continue to experience difficult business climate.

Within sector 138 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from to 2794.

Asset Turnover Ratio Definition

Select the Comparisons :

None ▼

Select the Ratio:

Asset Turnover▼

None ▼

Asset Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MHUA Asset Turnover Ratio	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Asset Change	13.25 %	75.67 %	-24.26 %	42.07 %	-25.64 %
Y / Y Revenue Change	-35.77 %	-	-	-	-6.92 %
Asset Turnover Ratio (TTM)	0.29	-	-	-	0.53
MHUA's Total Ranking	# 2794	#	#	#	#
Seq. Asset Change	-10.17 %	21.01 %	-17.37 %	26.07 %	39.35 %
Seq. Revenue Change	-	-	-	-	-

Asset Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 139
Healthcare Sector	# 404
Overall Market	# 2794

Asset Turnover Ratio Statistics
High	Average	Low
0.63	0.5	0.3
(Dec 31 2022)		(Dec 31 2025)

MHUA Company Profile • Back to MHUA Efficiency Comparisons • Compare MHUA Asset Turnover Ratio to its Competitors

Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector	Asset Turnover Ratio	Revenues for 12 Months ending Dec 31 2025	Assets at quarter ending Dec 31 2025
Lensar Inc	0.82	$ 58.435 Millions	$ 71.252 Millions
Acadia Pharmaceuticals Inc	0.82	$ 1,071.505 Millions	$ 1,313.221 Millions
Bioventus Inc	0.81	$ 566.845 Millions	$ 695.839 Millions
Ironwood Pharmaceuticals inc	0.81	$ 296.151 Millions	$ 365.781 Millions
Cadre Holdings inc	0.81	$ 609.628 Millions	$ 753.204 Millions
Casi Pharmaceuticals inc	0.81	$ 20.712 Millions	$ 25.650 Millions
Cybin Inc	0.80	$ 159.148 Millions	$ 198.101 Millions
Cue Biopharma Inc	0.80	$ 27.466 Millions	$ 34.204 Millions
Alnylam Pharmaceuticals Inc	0.80	$ 3,713.937 Millions	$ 4,649.456 Millions
Alpha Pro Tech Ltd	0.80	$ 58.537 Millions	$ 73.337 Millions
Airsculpt Technologies Inc	0.78	$ 151.818 Millions	$ 193.713 Millions
Davita Inc	0.78	$ 13,643.069 Millions	$ 17,411.996 Millions
Iradimed Corporation	0.78	$ 83.814 Millions	$ 107.919 Millions
Labcorp Holdings Inc	0.77	$ 13,951.700 Millions	$ 18,079.500 Millions
West Pharmaceutical Services Inc	0.77	$ 3,074.000 Millions	$ 3,986.700 Millions
Concentra Group Holdings Parent Inc	0.77	$ 2,163.417 Millions	$ 2,818.285 Millions
Gyre Therapeutics Inc	0.77	$ 116.588 Millions	$ 151.988 Millions
Irhythm Holdings Inc	0.76	$ 746.250 Millions	$ 976.346 Millions
Beone Medicines Ltd	0.76	$ 5,341.915 Millions	$ 6,990.270 Millions
Arrowhead Pharmaceuticals Inc	0.76	$ 1,090.981 Millions	$ 1,431.175 Millions
Msa Safety Inc	0.76	$ 1,874.113 Millions	$ 2,473.512 Millions
Bioaffinity Technologies Inc	0.75	$ 6.162 Millions	$ 8.201 Millions
Pharming Group N v	0.75	$ 375.634 Millions	$ 499.963 Millions
Vivos Therapeutics Inc	0.75	$ 16.542 Millions	$ 22.028 Millions
Harmony Biosciences Holdings inc	0.75	$ 868.111 Millions	$ 1,160.848 Millions
Masimo Corp	0.74	$ 1,526.200 Millions	$ 2,053.025 Millions
Adapthealth Corp	0.74	$ 3,244.857 Millions	$ 4,372.069 Millions
Delcath Systems Inc	0.74	$ 83.762 Millions	$ 113.031 Millions
Cytosorbents Corporation	0.74	$ 34.921 Millions	$ 47.176 Millions
Amicus Therapeutics inc	0.74	$ 632.828 Millions	$ 855.956 Millions

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.